360
Participants
Start Date
March 16, 2021
Primary Completion Date
August 31, 2021
Study Completion Date
October 27, 2021
Intervention Group: Infant Formula with hydrolyzed protein
Infants will receive infant formula during the first 120 days of life with optional follow up until 180 days of life (intervention formula manufactured from extensively hydrolysed whey protein).
Control Group: Infant Formula with intact protein
Infants will receive infant formula during the first 120 days of life with optional follow up until 180 days of life (control formula manufactured from intact cow's milk protein).
Evangelisches Waldkrankenhaus Spandau, Berlin
Collaborators (1)
Waldkrankenhaus Protestant Hospital, Spandau
OTHER
Biofortis, Merieux NutriSciences
INDUSTRY
HungaroTrial
UNKNOWN
HiPP GmbH & Co. Vertrieb KG
INDUSTRY